OCULOcular Therapeutix, Inc.

$11.39

What is the market doing?

What the tape says about OCUL

Ocular Therapeutix, Inc. is −7.5% over the past year while the S&P 500 is +20%: 28 points behind the market.

−7.5%

1-year return · S&P 500 +20%

vs 200-day average
+13%

vs 200-day average · a clear uptrend

RSI (14)
59

RSI (14) · neutral

Below its 52-week high
29%

Below its 52-week high

2024-08-15$5.93 – $16.11 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$11.39
1 monthS&P 500 −0.30%
+30%
1 yearS&P 500 +20%
−7.5%
5 yearsS&P 500 +85%
+3.6%
vs 50-day average$9.71
+17%
52-week high
$16.11
52-week low
$6.88
Annualised volatility
67%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$256K
Calendar-year price return
YearReturn
2026 (year to date)−6.2%
2025+42%
2024+91%
2023+59%
2022−60%
2021−66%
2020+424%
2019−0.75%
2018−11%
2017−47%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10−1.1%
Feb106 of 10+20%
Mar104 of 10−1.7%
Apr106 of 10−0.75%
May105 of 10−0.74%
Jun106 of 10+11%
Jul114 of 11−4.5%
Aug117 of 11+8.8%
Sep113 of 11−6.5%
Oct103 of 10−5.6%
Nov106 of 10+15%
Dec104 of 10+3.8%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.